326 related articles for article (PubMed ID: 31843588)
21. The survival detriment of venous thromboembolism with epithelial ovarian cancer.
Gunderson CC; Thomas ED; Slaughter KN; Farrell R; Ding K; Farris RE; Lauer JK; Perry LJ; McMeekin DS; Moore KN
Gynecol Oncol; 2014 Jul; 134(1):73-7. PubMed ID: 24793732
[TBL] [Abstract][Full Text] [Related]
22. The incidence of venous thromboembolism among patients with primary lung cancer.
Chew HK; Davies AM; Wun T; Harvey D; Zhou H; White RH
J Thromb Haemost; 2008 Apr; 6(4):601-8. PubMed ID: 18208538
[TBL] [Abstract][Full Text] [Related]
23. Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated?
Krepline AN; Christians KK; George B; Ritch PS; Erickson BA; Tolat P; Evans DB; Tsai S
J Surg Oncol; 2016 Oct; 114(5):581-586. PubMed ID: 27760280
[TBL] [Abstract][Full Text] [Related]
24. The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis.
Schorn S; Demir IE; Haller B; Scheufele F; Reyes CM; Tieftrunk E; Sargut M; Goess R; Friess H; Ceyhan GO
Surg Oncol; 2017 Mar; 26(1):105-115. PubMed ID: 28317579
[TBL] [Abstract][Full Text] [Related]
25. Renalase is a novel tissue and serological biomarker in pancreatic ductal adenocarcinoma.
Gao Y; Wang M; Guo X; Hu J; Chen TM; Finn SMB; Lacy J; Kunstman JW; Cha CH; Bellin MD; Robert ME; Desir GV; Gorelick FS
PLoS One; 2021; 16(9):e0250539. PubMed ID: 34587190
[TBL] [Abstract][Full Text] [Related]
26. A prospective clinical and biological database for pancreatic adenocarcinoma: the BACAP cohort.
Canivet C; Gourgou-Bourgade S; Napoléon B; Palazzo L; Flori N; Guibert P; Piessen G; Farges-Bancel D; Seitz JF; Assenat E; Vendrely V; Truant S; Vanbiervliet G; Berthelémy P; Garcia S; Gomez-Brouchet A; Buscail L; Bournet B;
BMC Cancer; 2018 Oct; 18(1):986. PubMed ID: 30326968
[TBL] [Abstract][Full Text] [Related]
27. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
28. Initial Misdiagnosis of Proximal Pancreatic Adenocarcinoma Is Associated with Delay in Diagnosis and Advanced Stage at Presentation.
Swords DS; Mone MC; Zhang C; Presson AP; Mulvihill SJ; Scaife CL
J Gastrointest Surg; 2015 Oct; 19(10):1813-21. PubMed ID: 26286368
[TBL] [Abstract][Full Text] [Related]
29. Predictors of Resectability and Survival in Patients With Borderline and Locally Advanced Pancreatic Cancer who Underwent Neoadjuvant Treatment With FOLFIRINOX.
Michelakos T; Pergolini I; Castillo CF; Honselmann KC; Cai L; Deshpande V; Wo JY; Ryan DP; Allen JN; Blaszkowsky LS; Clark JW; Murphy JE; Nipp RD; Parikh A; Qadan M; Warshaw AL; Hong TS; Lillemoe KD; Ferrone CR
Ann Surg; 2019 Apr; 269(4):733-740. PubMed ID: 29227344
[TBL] [Abstract][Full Text] [Related]
30. Clinical Significance of Venous Thromboembolism in Patients with Advanced Cholangiocarcinoma.
Kim JS; Paik WH; Lee SH; Lee MW; Park N; Choi JH; Cho IR; Ryu JK; Kim YT
Gut Liver; 2024 Jan; 18(1):165-173. PubMed ID: 37009669
[TBL] [Abstract][Full Text] [Related]
31. Venous thromboembolism in metastatic pancreatic cancer.
Laderman L; Sreekrishnanilayam K; Pandey RK; Handorf E; Blumenreich A; Sorice KA; Lynch SM; Cheema K; Nagappan L; Sosa IR; Dotan E; Vijayvergia N
Eur J Haematol; 2023 Jun; 110(6):706-714. PubMed ID: 36941225
[TBL] [Abstract][Full Text] [Related]
32. Estimation of Extracellular Volume Fraction With Routine Multiphasic Pancreatic Computed Tomography to Predict the Survival of Patients With Stage IV Pancreatic Ductal Adenocarcinoma.
Fukukura Y; Kumagae Y; Higashi R; Hakamada H; Nakajo M; Maemura K; Arima S; Yoshiura T
Pancreas; 2019; 48(10):1360-1366. PubMed ID: 31688602
[TBL] [Abstract][Full Text] [Related]
33. Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database Study.
Bergquist JR; Puig CA; Shubert CR; Groeschl RT; Habermann EB; Kendrick ML; Nagorney DM; Smoot RL; Farnell MB; Truty MJ
J Am Coll Surg; 2016 Jul; 223(1):52-65. PubMed ID: 27049786
[TBL] [Abstract][Full Text] [Related]
34. Incidence and risk of venous thromboembolism according to primary treatment type in women with endometrial cancer: a population-based study.
Yuk JS; Lee B; Kim K; Kim MH; Seo YS; Hwang SO; Cho YK; Kim YB
BMC Cancer; 2021 Oct; 21(1):1166. PubMed ID: 34717579
[TBL] [Abstract][Full Text] [Related]
35. Is chronic hepatitis B infection a protective factor for the progression of advanced pancreatic ductal adenocarcinoma? An analysis from a large multicenter cohort study.
Chen Q; Ning Z; Wang L; Ying H; Dong S; Zhang C; Shen X; Guo Y; Chen H; Zhu X; Shen Y; Shi W; Hua Y; Wang K; Lin J; Xu L; Chen L; Feng L; Zhang X; Xie J; Sun B; Sun Y; Gu W; Kang M; Tang Z; Chen Z; Chen Z; Liu L; Yu J; Li Z; Meng Z
Oncotarget; 2016 Dec; 7(51):85603-85612. PubMed ID: 27811354
[TBL] [Abstract][Full Text] [Related]
36. Outcomes of Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma in the Netherlands: A Nationwide Retrospective Analysis.
de Rooij T; Tol JA; van Eijck CH; Boerma D; Bonsing BA; Bosscha K; van Dam RM; Dijkgraaf MG; Gerhards MF; van Goor H; van der Harst E; de Hingh IH; Kazemier G; Klaase JM; Molenaar IQ; Patijn GA; van Santvoort HC; Scheepers JJ; van der Schelling GP; Sieders E; Busch OR; Besselink MG;
Ann Surg Oncol; 2016 Feb; 23(2):585-91. PubMed ID: 26508153
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism during primary treatment of ovarian clear cell carcinoma is associated with decreased survival.
Diaz ES; Walts AE; Karlan BY; Walsh CS
Gynecol Oncol; 2013 Dec; 131(3):541-5. PubMed ID: 24041880
[TBL] [Abstract][Full Text] [Related]
38. Influence of Tumor Thrombus on Occurrence of Distant Venous Thromboembolism and Survival in Patients With Renal Cell Carcinoma After Surgery.
Park H; Jeong CW; Yuk H; Ku JH; Kim HH; Kwak C; Kim I
Clin Appl Thromb Hemost; 2019; 25():1076029618823288. PubMed ID: 30808214
[TBL] [Abstract][Full Text] [Related]
39. Body mass index does not affect the survival of pancreatic cancer patients.
Jiang QL; Wang CF; Tian YT; Huang H; Zhang SS; Zhao DB; Ma J; Yuan W; Sun YM; Che X; Zhang JW; Chu YM; Zhang YW; Chen YT
World J Gastroenterol; 2017 Sep; 23(34):6287-6293. PubMed ID: 28974895
[TBL] [Abstract][Full Text] [Related]
40. Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study.
Kenmotsu H; Notsu A; Mori K; Omori S; Tsushima T; Satake Y; Miki Y; Abe M; Ogiku M; Nakamura T; Takagi M; Ochiai H; Yasui H; Takahashi T
Cancer Med; 2021 Feb; 10(3):895-904. PubMed ID: 33421344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
